148 related articles for article (PubMed ID: 36654969)
1. Urinary and Kidney Podocalyxin and Podocin Levels in Diabetic Kidney Disease: A Kidney Biopsy Study.
Zeng L; Fung WW; Chan GC; Ng JK; Chow KM; Szeto CC
Kidney Med; 2023 Jan; 5(1):100569. PubMed ID: 36654969
[TBL] [Abstract][Full Text] [Related]
2. Urinary podocyte stress marker as a prognostic indicator for diabetic kidney disease.
Zeng L; Ng JK; Fung WW; Chan GC; Chow KM; Szeto CC
BMC Nephrol; 2024 Jan; 25(1):32. PubMed ID: 38267859
[TBL] [Abstract][Full Text] [Related]
3. Intrarenal and Urinary Glycogen Synthase Kinase-3 Beta Levels in Diabetic and Nondiabetic Chronic Kidney Disease.
Zeng L; Ng JK; Fung WW; Chan GC; Chow KM; Szeto CC
Kidney Blood Press Res; 2023; 48(1):241-248. PubMed ID: 36940673
[TBL] [Abstract][Full Text] [Related]
4. Podocyte loss in human hypertensive nephrosclerosis.
Wang G; Lai FM; Kwan BC; Lai KB; Chow KM; Li PK; Szeto CC
Am J Hypertens; 2009 Mar; 22(3):300-6. PubMed ID: 19131934
[TBL] [Abstract][Full Text] [Related]
5. Urinary podocyte markers in diabetic kidney disease.
Li C; Szeto CC
Kidney Res Clin Pract; 2024 Feb; ():. PubMed ID: 38325865
[TBL] [Abstract][Full Text] [Related]
6. Kidney microRNA-21 Expression and Kidney Function in IgA Nephropathy.
Szeto CC; Ng JK; Fung WW; Luk CC; Wang G; Chow KM; Lai KB; Li PK; Lai FM
Kidney Med; 2021; 3(1):76-82.e1. PubMed ID: 33604541
[TBL] [Abstract][Full Text] [Related]
7. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of podocyte-associated mRNAs in patients with proliferative or non-proliferative glomerulopathies.
Rodrigues PG; Bringhenti RN; do Nascimento JF; Joelsons G; dos Santos M; Pereira S; Veronese FV
Int J Clin Exp Pathol; 2014; 7(5):2185-98. PubMed ID: 24966927
[TBL] [Abstract][Full Text] [Related]
9. Expression of podocyte-associated molecules in acquired human kidney diseases.
Koop K; Eikmans M; Baelde HJ; Kawachi H; De Heer E; Paul LC; Bruijn JA
J Am Soc Nephrol; 2003 Aug; 14(8):2063-71. PubMed ID: 12874460
[TBL] [Abstract][Full Text] [Related]
10. Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy.
Fayed A; Rahman Tohamy IA; Kahla H; Elsayed NM; El Ansary M; Saadi G
Diabetes Metab Syndr; 2019; 13(5):2849-2854. PubMed ID: 31425946
[TBL] [Abstract][Full Text] [Related]
11. Podocyte Injury in Autosomal Dominant Polycystic Kidney Disease.
Cebeci E; Ekinci I; Gursu M; Coskun C; Karadag S; Uzun S; Behlul A; Senel TE; Kazancioglu R; Ozturk S
Nephron; 2019; 142(4):311-319. PubMed ID: 31117091
[TBL] [Abstract][Full Text] [Related]
12. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy.
Zheng M; Lv LL; Ni J; Ni HF; Li Q; Ma KL; Liu BC
PLoS One; 2011; 6(5):e20431. PubMed ID: 21655212
[TBL] [Abstract][Full Text] [Related]
13. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
[TBL] [Abstract][Full Text] [Related]
14. Messenger RNA expression of target genes in the urinary sediment of patients with chronic kidney diseases.
Szeto CC; Chan RW; Lai KB; Szeto CY; Chow KM; Li PK; Lai FM
Nephrol Dial Transplant; 2005 Jan; 20(1):105-13. PubMed ID: 15561743
[TBL] [Abstract][Full Text] [Related]
15. Urinary dedifferentiated podocytes as a non-invasive biomarker of lupus nephritis.
Perez-Hernandez J; Olivares MD; Forner MJ; Chaves FJ; Cortes R; Redon J
Nephrol Dial Transplant; 2016 May; 31(5):780-9. PubMed ID: 26932688
[TBL] [Abstract][Full Text] [Related]
16. Urinary mRNA Signatures as Predictors of Renal Function Decline in Patients With Biopsy-Proven Diabetic Kidney Disease.
Lee YH; Seo JW; Kim M; Tae D; Seok J; Kim YG; Lee SH; Kim JS; Hwang HS; Jeong KH; Moon JY
Front Endocrinol (Lausanne); 2021; 12():774436. PubMed ID: 34858345
[TBL] [Abstract][Full Text] [Related]
17. Urinary podocyte markers in kidney diseases.
Zeng L; Szeto CC
Clin Chim Acta; 2021 Dec; 523():315-324. PubMed ID: 34666027
[TBL] [Abstract][Full Text] [Related]
18. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
Ma RX; Zhao N; Zhang W
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
[TBL] [Abstract][Full Text] [Related]
19. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
[TBL] [Abstract][Full Text] [Related]
20. Messenger RNA expression of podocyte-associated molecules in the urinary sediment of patients with diabetic nephropathy.
Wang G; Lai FM; Lai KB; Chow KM; Li KT; Szeto CC
Nephron Clin Pract; 2007; 106(4):c169-79. PubMed ID: 17596726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
